We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Amber Lockridge is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 2018 — 2019 |
Lockridge, Amber D |
F31Activity Code Description:
To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
Molecular Mechanisms of O-Glcnacylation in Prediabetic Beta-Cell Hypersecretion During Diet-Induced Obesity @ University of Minnesota
PROJECT SUMMARY O-GlcNAc transferase (OGT) is highly expressed in pancreatic ?-cells where it exclusively catalyzes the post- translational and dynamic glycosylation of select cytosolic proteins (referred to as O-GlcNAcylation). OGT is a multi-nutrient sensor and the ?-cell OGT knockout mouse develops severe type 2 diabetes, suggesting OGT plays a role in glucose homeostasis and metabolic disease. The long-term goal of this research is to understand how protein O-GlcNAcylation contributes to ?-cell health and function under various nutrient environments. While some studies have investigated ?-cell O-GlcNAcylation during hyperglycemia and in diabetic decompensation, little is known about OGT's role during hyperlipidemia or the prediabetic phase of obesity when ?-cell hyperinsulinemia compensates for peripheral insulin resistance to maintain euglycemia and prevent the onset of full diabetes. Our preliminary data shows that islet (?-cell) O-GlcNAcylation increases in response to obesity and that OGT-loss mice do not develop prediabetic hyperinsulinemia in response to high fat diet (HFD), in part due to impaired potentiation of islet insulin secretion. Our central hypothesis is that in response to diet-induced obesity, OGT is required for the initiation and maintenance of ?-cell hypersecretion by tightly controlling the O-GlcNAcylation status of specific protein regulators that modulate stimulus-secretion coupling. The objective of this proposal is to identify OGT-driven mechanisms and protein regulators that underlie prediabetic secretory adaptation. Specific Aim 1 will evaluate lipid signaling and mitochondrial ATP production, well-known obesity-driven mechanisms of ?-cell secretory potentiation, in inducible ?-cell OGT KO (i?OGT KO) mice under HFD. Specific Aim 2 will characterize human and mouse islet O-GlcNAcylation in response to obesity and use a differential gene expression analysis (RNA-seq) to identify protein regulators (i.e. of lipid and mitochondrial metabolism) whose O-GlcNAcylated expression is increased by diet-induced obesity. This investigation is innovative because very little is known about in vivo ?-cell O-GlcNAcylation in the context of hyperlipidemia and OGT-regulation of islet lipid metabolism is unexplored. If successful, this proposal will generate a set of OGT-responsive mechanisms and a prioritized list of critical proteins to guide future cause-and-effect studies that can directly test the role of OGT-targets in initiating or maintaining specific structural and functional adaptations that contribute to ?-cell success or failure in diet-induced obesity. The significance of this research is in revealing a novel role of the nutrient-sensor OGT in regulating adaptive hyperinsulinemia, especially contributions by lipid and mitochondrial metabolism, and revealing new therapeutic targets that may prevent prediabetic progression to type 2 diabetes in obese individuals.
|
0.958 |